Nuvation Bio
Valuation
$38.1M
Funding
$0
Founded
2018
Nuvation Bio revenue, CEO David Hung, M.D., team size, customer count, churn, and more in 2026.
Nuvation Bio is a global oncology company focused on tackling some of the toughest challenges in cancer treatment.
Last updated
Nuvation Bio Revenue
We do not have information about Nuvation Bio's revenue yet.
Nuvation Bio Valuation, Funding Rounds
Nuvation Bio's most recent disclosed valuation is $38.1M.
Nuvation Bio is a bootstrapped SaaS company, self-funded since its founding in 2018, with no outside investment to date.
| Year | Round | Amount | Valuation | % Sold |
|---|
Nuvation Bio Employees & Team Size
We do not have information about Nuvation Bio's team yet.
Founder / CEO
Q&A
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
Customers
We do not have customer count information for Nuvation Bio yet.
Frequently Asked Questions about Nuvation Bio
What is Nuvation Bio's revenue?
GetLatka has not confirmed a public revenue figure for Nuvation Bio.
Who is the CEO of Nuvation Bio?
The CEO of Nuvation Bio is David Hung, M.D..
How much funding does Nuvation Bio have?
Nuvation Bio raised $0.
How many employees does Nuvation Bio have?
Nuvation Bio has 0 employees.
Where is Nuvation Bio headquarters?
Nuvation Bio is headquartered in New York, New York, United States.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .